Influenza Diagnostics Market Forecast 2023-2028: Industry Trends, Size, Share Analysis
IMARC Group's report titled "Influenza Diagnostics Market Report by Product (Test Kit and Reagents, Instruments, and Others), Test Type (Molecular Diagnostic Tests, Traditional Diagnostic Tests), Type of Flu (Type A Flu, Type B Flu, Type C Flu), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2023-2028". The global influenza diagnostics market size reached US$ 893.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,461.7 Million by 2028, exhibiting a growth rate (CAGR) of 6.55% during 2023-2028.
Grab a sample PDF of this report: https://www.imarcgroup.com/influenza-diagnostics-market/requestsample
Factors Affecting the Growth of the Influenza Diagnostics Industry:
- Increasing Awareness About Early Diagnosis:
The rising awareness among individuals about the importance of early influenza diagnosis is propelling the growth of the market. In line with this, people are becoming more informed about the risks associated with influenza and the potential for complications. Furthermore, the increasing focus on early disease detection is impelling the market growth. Apart from this, healthcare professionals are recommending testing as a crucial step in managing the virus effectively. Moreover, the growing demand for diagnostic tests, as individuals and healthcare providers are recognizing the benefits of timely treatment, is offering a positive market outlook.
- Rising Health Concerns:
The escalating demand for influenza diagnostics on account of increasing health concerns among individuals is supporting the market growth. In addition, governing agencies of numerous countries are investing in influenza diagnostics to prepare for and respond to health emergencies. Apart from this, the rising need for diagnostic testing to prevent severe illness and complications is propelling the market growth. Furthermore, influenza can lead to severe complications, including pneumonia, hospitalization, and death. The recognition of these potential consequences encourages individuals to seek diagnostic testing for quick treatment and to reduce the spread of the virus.
- Technological Advancements:
The introduction of advanced tools like polymerase chain reaction (PCR) and rapid antigen tests assist in improving accuracy, sensitivity, and speed in diagnosing influenza infections. In line with this, these innovations are making testing more accessible and convenient for both healthcare professionals and patients. Furthermore, the rising need for more efficient and accurate diagnostic solutions among patients is bolstering the market growth. Apart from this, the integration of advanced technologies like artificial intelligence (AI) and machine learning (ML) algorithms to analyze diagnostic data rapidly is impelling the market growth.
Leading Companies Operating in the Global Influenza Diagnostics Industry:
Abbott Laboratories
Becton Dickinson and Company
Coris Bioconcept
Danaher Corporation
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd (Roche Holding AG)
Hologic Inc.
Meridian Bioscience Inc.
Qiagen N.V
Quidel Corporation
Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
Siemens Healthineers AG (Siemens AG)
Influenza Diagnostics Market Report Segmentation:
By Product:
Test Kit and Reagents
Instruments
Others
Test kit and reagents represent the largest segment as they enable healthcare professionals to diagnose influenza infections quickly and accurately, facilitating timely medical interventions and public health responses.
By Test Type:
Molecular Diagnostic Tests
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Tests
Other Molecular Tests
Traditional Diagnostic Tests
Rapid Influenza Diagnostic Tests
Viral Culture Tests
Direct Fluorescent Antibody Test
Serological Tests
Traditional diagnostic tests hold the biggest market share, which can be attributed to the rising demand for rapid results.
By Type of Flu:
Type A Flu
Type B Flu
Type C Flu
Type A flu accounts for the largest market share due to the increasing need to monitor and diagnose strains.
By End User:
Hospitals
Diagnostic Laboratories
Others
Hospitals exhibit a clear dominance in the market on account of the rising focus on immediate access to diagnostic services for patients with flu-like symptoms.
Regional Insights:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
North America enjoys the leading position in the influenza diagnostics market, which can be accredited to the development of advanced diagnostic technologies and methodologies.
Global Influenza Diagnostics Market Trends:
Influenza outbreaks occur predictably every year during flu seasons. In addition, healthcare providers and individuals are seeking test options to confirm influenza infections, enabling quick treatment. Besides this, the reliability of diagnostic tools during these outbreaks is crucial, making their use essential.
Moreover, the increasing adoption of point-of-care influenza tests in clinics and pharmacies due to their enhanced convenience is contributing to the market growth. Apart from this, governing agencies of various countries are organizing vaccination campaigns, which is impelling the market growth.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163